Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy-A meta-analysis.
about
Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsRisk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysis.Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer.Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.
P2860
Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy-A meta-analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-vascular endothelial grow ...... chemotherapy-A meta-analysis.
@ast
Anti-vascular endothelial grow ...... chemotherapy-A meta-analysis.
@en
type
label
Anti-vascular endothelial grow ...... chemotherapy-A meta-analysis.
@ast
Anti-vascular endothelial grow ...... chemotherapy-A meta-analysis.
@en
prefLabel
Anti-vascular endothelial grow ...... chemotherapy-A meta-analysis.
@ast
Anti-vascular endothelial grow ...... chemotherapy-A meta-analysis.
@en
P2860
P921
P1433
P1476
Anti-vascular endothelial grow ...... chemotherapy-A meta-analysis.
@en
P2093
Shenhong Wu
P2860
P304
P356
10.3109/0284186X.2011.581689
P577
2011-05-09T00:00:00Z